CHONDROGUARD
Angiotech Pharmaceuticals, Inc.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 78539517 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Domestic Representative | Kevin S. Costanza |
| Attorney Name | Kevin S. Costanza |
| Attorney Docket Number | 110129.20025 |
| Law Office Assigned | M10 |
| Employee Name | CAPSHAW, DANIEL |
Timeline
| 2004-12-29 | Application Filed |
| 2008-12-26 | Abandon |
| 2009-01-22 | Location: TMO LAW OFFICE 110 - EXAMINING ATTORNEY ASSIGNED |
| 2009-01-22 | Status: Dead/Abandoned |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Angiotech Pharmaceuticals, Inc. |
| Address | 1618 Station Street Vancouver CA V6A 1B6 |
| Legal Entity Type | Corporation |
| Legal Entity State | CA |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 10 |
| U.S. Codes: | 026,039,044 |
| Type Code | Type |
|---|---|
| GS0051 | pharmaceutical preparations, namely, surgical and injectable gels for the treatment of skeletal, including bone and cartilage, injuries and conditions |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2005-01-12 | 1 NWAP I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2005-01-27 | 2 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2005-01-28 | 3 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2005-01-28 | 4 GNRT F:First Action |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2005-07-28 | 5 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2005-07-28 | 6 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2005-08-09 | 7 TEME I:Incoming Correspondence |
| EXAMINERS AMENDMENT -WRITTEN | 2005-08-16 | 8 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2005-08-16 | 9 GNEA O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2005-08-17 | 10 XAEC I:Incoming Correspondence |
| SUSPENSION LETTER WRITTEN | 2005-08-18 | 11 CNSL R:Renewal |
| LETTER OF SUSPENSION E-MAILED | 2005-08-18 | 12 GNSL S: |
| SUSPENSION INQUIRY WRITTEN | 2006-03-22 | 13 CNSI R:Renewal |
| INQUIRY TO SUSPENSION E-MAILED | 2006-03-22 | 14 GNSI S: |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2006-09-22 | 15 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2006-09-22 | 16 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2006-09-29 | 17 TEME I:Incoming Correspondence |
| SUSPENSION LETTER WRITTEN | 2006-10-18 | 18 CNSL R:Renewal |
| LETTER OF SUSPENSION E-MAILED | 2006-10-18 | 19 GNSL S: |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2006-10-24 | 20 TCCA I:Incoming Correspondence |
| ASSIGNED TO LIE | 2007-05-02 | 21 ALIE A:Allowance for Publication |
| REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | 2007-05-02 | 22 RCSC S: |
| REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | 2007-11-21 | 23 RCSC S: |
| ASSIGNED TO LIE | 2008-05-22 | 24 ALIE A:Allowance for Publication |
| LIE CHECKED SUSP - TO ATTY FOR ACTION | 2008-05-22 | 25 RCCK S: |
| SUSPENSION INQUIRY WRITTEN | 2008-06-26 | 26 CNSI R:Renewal |
| INQUIRY TO SUSPENSION E-MAILED | 2008-06-26 | 27 GNSI S: |
| NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | 2008-06-26 | 28 GNS2 O:Outgoing Correspondence |
| ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | 2009-01-22 | 29 ABN2 O:Outgoing Correspondence |
| ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | 2009-01-22 | 30 MAB2 O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 CHONDROGUARD 85571146 4265797 Live/Registered |
Arthrex, Inc. 2012-03-15 |
 CHONDROGUARD 78539517 not registered Dead/Abandoned |
Angiotech Pharmaceuticals, Inc. 2004-12-29 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 